Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
saline solution (Institut Bergonié)
- Development stage
- Unknown
- Lead developer
- Institut Bergonié
- Modality
- Small Molecules
- Administration
- Intrapleural
01
Overview
Reference-Institut Bergonié-postoperative pain refers to the saline solution control arm used in a Phase 2 clinical trial (NCT00163319) evaluating the efficacy of intrapleural ropivacaine for post-thoracotomy pain. In this study, 8 ml of 0.9% saline was administered every 6 hours for 48 hours via an intrapleural catheter. As a placebo, it lacks active analgesic properties and serves as a comparator to measure the therapeutic effect of the experimental local anesthetic in cancer patients undergoing thoracic surgery. The trial was sponsored by Institut Bergonié to determine the analgesic efficacy and pharmacokinetics of ropivacaine in this specific surgical context.
- Other names
- sodium chloride 0.9%physiological saline0.9% NaCl
Beyond the preview
Go deeper on saline solution (Institut Bergonié).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on saline solution (Institut Bergonié).